Showing results (1551-1560 of 1,799) with videos related to
Sort By:
Pageof 180
Mabs|September 5, 2015
Therapeutic drug monitoring of eculizumab: Rationale for an individualized dosing schedulePhilippe Gatault, Guillaume Brachet, David Ternant, et al.Mabs|September 5, 2015
Stability engineering of anti-EGFR scFv antibodies by rational design of a lambda-to-kappa swap of the VL framework using a structure-guided approachAndreas Lehmann, Josephine H F Wixted, Maxim V Shapovalov, et al.Mabs|August 1, 2015
Consistency of quality attributes for the glycosylated monoclonal antibody Humira® (adalimumab)Paul W Tebbey, Amy Varga, Michael Naill, et al.Mabs|August 21, 2015
Toward the complete characterization of host cell proteins in biotherapeutics via affinity depletions, LC-MS/MS, and multivariate analysisJames A Madsen, Victor Farutin, Theresa Carbeau, et al.Mabs|December 9, 2014
Mining the human autoantibody repertoire: isolation of potent IL17A-neutralizing monoclonal antibodies from a patient with thymomaRoger R Beerli, Monika Bauer, Andrea Fritzer, et al.Mabs|December 9, 2014
Resolving self-association of a therapeutic antibody by formulation optimization and molecular approachesPaul Casaz, Elisabeth Boucher, Rachel Wollacott, et al.Mabs|December 9, 2014
IgG4 can induce an M2-like phenotype in human monocyte-derived macrophages through FcγRIJennifer F A Swisher, Devin A Haddad, Anna G McGrath, et al.Mabs|December 9, 2014
Remediating agitation-induced antibody aggregation by eradicating exposed hydrophobic motifsRutilio H Clark, Ramil F Latypov, Cyr De Imus, et al.Mabs|December 9, 2014
High throughput functional epitope mapping: revisiting phage display platform to scan target antigen surfaceGertrudis Rojas, Yaima Tundidor, Yanelys Cabrera InfanteMabs|December 9, 2014
Continuous bioprocessing: the real thing this time? 10(th) Annual bioProcessUK Conference, December 3-4, 2013, London, UKSuzanne S Farid, Bill Thompson, Andrew DavidsonPageof 180